Q1 2023 Holdings
Filed 2023-05-18 | 64 holdings | $358.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Relmada Therapeutics(RLMD) | COM | 75955J402 | $22.5K | 10,000 | 0.0% |
| Black Diamond Therapeutic | COM | 0920E3105 | $82.3K | 44,000 | 0.0% |
| Ideaya Biosciences(IDYA) | COM | 45166A102 | $260.9K | 19,000 | 0.1% |
| Iovance Biotherapeutics(IOVA) | COM | 462260100 | $341.6K | 56,000 | 0.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $463.9K | 17,000 | 0.1% |
| Biocryst Pharms.(BCRX) | COM | 09058V103 | $475.4K | 57,000 | 0.1% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $501.5K | 15,000 | 0.1% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM | 46333X108 | $631.2K | 60,000 | 0.2% |
| Insmed Inc(INSM) | COM | 457669307 | $682.1K | 40,100 | 0.2% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $717.9K | 23,500 | 0.2% |
| Hutchmed China LTD(HCM) | SPONSORED ADS | 44842L103 | $885.4K | 68,000 | 0.2% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $889.6K | 154,708 | 0.2% |
| Intellia Therapeutics(NTLA) | COM | 45826J105 | $894.0K | 24,000 | 0.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $912.4K | 25,500 | 0.3% |
| Novavax Inc(NVAX) | COM | 670002401 | $924.9K | 132,500 | 0.3% |
| I-Mab(NBP) | SPONSORED ADS | 44975P103 | $1.1M | 310,499 | 0.3% |
| Rocket Pharms.(RCKT) | COM | 77313F106 | $1.1M | 63,000 | 0.3% |
| Ionis Pharms.(IONS) | COM | 462222100 | $1.5M | 43,000 | 0.4% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $1.5M | 34,200 | 0.4% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $1.6M | 67,500 | 0.5% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $1.7M | 45,500 | 0.5% |
| Guardant Health(GH) | COM | 40131M109 | $1.7M | 74,500 | 0.5% |
| Legend Biotech(LEGN) | SPONSORED ADS | 52490G102 | $1.8M | 38,000 | 0.5% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $1.9M | 32,000 | 0.5% |
| Denali Therapeutics(DNLI) | COM | 24823R105 | $2.0M | 86,575 | 0.6% |
| Karuna Therapeutics Inc | COM | 48576A100 | $2.0M | 11,000 | 0.6% |
| Apellis Pharms.(APLS) | COM | 03753U106 | $2.1M | 31,700 | 0.6% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $2.4M | 457,892 | 0.7% |
| Jazz Pharms.(JAZZ) | SHS USD | G50871105 | $2.5M | 17,200 | 0.7% |
| Zai Lab Ltd ADR (V1 Ord)(ZLAB) | ADR | 98887Q104 | $2.6M | 78,958 | 0.7% |
| Ascendis Pharma ADR(ASND) | Sponsored ADR | 04351P101 | $3.2M | 29,400 | 0.9% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $3.2M | 141,019 | 0.9% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $3.3M | 88,000 | 0.9% |
| Acadia Pharmaceuticals in(ACAD) | COM | 004225108 | $4.1M | 216,000 | 1.1% |
| Erasca Inc(ERAS) | COM | 29479A108 | $4.3M | 1,426,000 | 1.2% |
| PTC Therapeutics(PTCT) | COM | 69366J200 | $4.5M | 93,000 | 1.3% |
| Astrazeneca PLC Sponsored(AZN) | SPONSORED ADR | 046353108 | $4.5M | 65,000 | 1.3% |
| Gilead Sciences(GILD) | COM | 375558103 | $4.8M | 57,584 | 1.3% |
| Krystal Biotech(KRYS) | COM | 501147102 | $4.9M | 61,000 | 1.4% |
| Beigene ADR(ONC) | Sponsored ADR | 07725L102 | $4.9M | 22,700 | 1.4% |
| Dyne Therapeutics(DYN) | COM | 26818M108 | $5.0M | 433,751 | 1.4% |
| Biomarin Pharm.(BMRN) | COM | 09061G101 | $5.7M | 58,656 | 1.6% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $5.9M | 183,000 | 1.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $5.9M | 21,400 | 1.7% |
| Illumina Inc(ILMN) | COM | 452327109 | $6.2M | 26,500 | 1.7% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $6.3M | 573,530 | 1.8% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $6.4M | 28,500 | 1.8% |
| Chinook Therapeutics(290A) | COM | 16961L106 | $7.4M | 319,989 | 2.1% |
| Vera Therapeutics(VERA) | CL A | 92337R101 | $7.7M | 1,002,257 | 2.2% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $7.8M | 143,500 | 2.2% |